Even when these medications are used in appropriate clinical circumstances, it is important to have a multifaceted lifestyle plan in place when weaning off these medications
The second class is inhibitors of the GLP-1 degrading enzyme, dipeptidyl pepitidase IV (Sitagliptin and related drugs) which can be given orally and increase the plasma level of GLP-1 and other peptides degraded by DPP-4
In summary, observational studies have not found an increased risk of PDAC during short term follow-up
It's important to understand that these medications cannot selectively target belly fat or produce "spot reduction." They promote generalized fat loss throughout the body, with the distribution influenced by individual factors including genetics, sex, age, and baseline body composition
To get the most out of your treatment, it is helpful to support your bodys natural pathways
And yes, most patients continue using Ozempic without serious issues